5. Individuals with unexplained chronic cough may go through a therapeutic trial of gabapentin as long as the adverse effects and the risk-advantage profile are told the patient prior to starting the regimen. The individual and provider should also reassess the risk-benefit profile at the 6-month mark before continuing the medication, too. The researchers suggested that dosing for gabapentin should be recommended using an escalation plan starting at 300 mg a day with an increase of doses added each day until a optimum tolerable dose is achieved—no more than 1800 mg a time in 2 divided dosages. 6. If the sufferers have a negative workup for acid gastroesophageal reflux disease, proton pump inhibitor therapy ought never to be prescribed.This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent information service, is a program of the Kaiser Family Foundation, a nonpartisan healthcare policy research firm unaffiliated with Kaiser Permanente.. Two Measures of Center Health Might Hint at Seniors’ Independence: – MONDAY, Aug. 31, 2015 – – Seniors with an increased resting heart rate and lower heart rate variability are less in a position to treatment for themselves, a fresh study finds.